Literature DB >> 1182138

The intermicellar bile salt concentration in equilibrium with the mixed-micelles of human bile.

W C Duane.   

Abstract

The intermicellar bile salt concentration in equilibrium with the bile salt-lecithin-cholesterol mixed-micelle has been studied in human bile. Equilibrium-dialysis, used to measure the biliary intermicellar bile salt concentration, has been validated as an applicable method by studying the cholate-lecithin mixed-micelle, for which intermicellar bile salt concentration values have previously been reported. The intermicellar bile salt concentration of bile was essentially independent of ionic strength in the range 0.05-0.15 M chloride. Simple dilution of bile lowered the intermicellar bile salt concentration (about 2/3 reduction for each two-fold dilution). This reduction occurred because of a simultaneous decrease in the molar ration of bile salt/phospholipid in the micelle. Dilution of micelles with micellar bile salt/phospholipid held constant did not affect the intermicellar bile salt concentration. The relationship between intermicellar bile salt concentration and micellar bile salt/phospholipid, defined in the dilution studies, was linear in the range of study. For a composite of five biles, this relationship was described by the equation: intermicellar bile salt concentration = 1.27 (bile salt/phsopholipid) + 0.538. Data obtained on an artificial bile agreed closely with the results obtained on bile suggesting that the other constituents of bile did not affect this analysis. These findings may be helpful in understanding the process of micellar cholesterol solubilization in bile.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1182138     DOI: 10.1016/0005-2760(75)90143-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Hydrolysis of intralipid by pancreatic lipase and phospholipase A2-gel filtration studies.

Authors:  R Grataroli; M Charbonnier; G Nalbone; D Lairon; C Chabert; J C Hauton; H Lafont
Journal:  Lipids       Date:  1985-11       Impact factor: 1.880

2.  Incorporation of hormone-sensitive lipase into phosphatidylcholine vesicles.

Authors:  C Holm; G Fredrikson; R Sundler; P Belfrage
Journal:  Lipids       Date:  1990-05       Impact factor: 1.880

3.  Colonic absorption of unconjugated bile acids: perfusion studies in man.

Authors:  H S Mekhjian; S F Phillips; A F Hofmann
Journal:  Dig Dis Sci       Date:  1979-07       Impact factor: 3.199

4.  Physicochemical and physiological properties of cholylsarcosine. A potential replacement detergent for bile acid deficiency states in the small intestine.

Authors:  J Lillienau; C D Schteingart; A F Hofmann
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

5.  Phosphatidylcholine as substrate for human pancreatic phospholipase A2. Importance of the physical state of the substrate.

Authors:  B Borgström
Journal:  Lipids       Date:  1993-05       Impact factor: 1.880

6.  Mechanism by which bile salt disrupts the gastric mucosal barrier in the dog.

Authors:  W C Duane; D M Wiegand
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

7.  Structural characterization of the micelle-vesicle transition in lecithin-bile salt solutions.

Authors:  M A Long; E W Kaler; S P Lee
Journal:  Biophys J       Date:  1994-10       Impact factor: 4.033

8.  Transport of sodium, chloride, and taurocholate by cultured rat hepatocytes.

Authors:  B F Scharschmidt; J E Stephens
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

Review 9.  Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades.

Authors:  Alan F Hofmann; Lee R Hagey
Journal:  J Lipid Res       Date:  2014-05-17       Impact factor: 5.922

10.  Purification of the human anionic polypeptide fraction of the apo-bile lipoprotein complex by zonal ultracentrifugation.

Authors:  M Martigne; N Domingo; H Lafont; G Nalbone; J C Hauton
Journal:  Lipids       Date:  1985-12       Impact factor: 1.880

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.